Production (Stage)
Xeris Biopharma Holdings, Inc.
XERS
$4.83
-$0.05-1.03%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -18.40% | 3.20% | -10.53% | -11.20% | 20.57% |
| Total Receivables | 14.64% | -1.76% | -3.07% | 13.43% | -4.55% |
| Inventory | 9.37% | 6.77% | 4.98% | 5.13% | 5.25% |
| Prepaid Expenses | -19.02% | 4.36% | -2.92% | -3.68% | 32.16% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -2.49% | 2.99% | -4.43% | -1.70% | 10.89% |
|
|
|||||
| Total Current Assets | -2.49% | 2.99% | -4.43% | -1.70% | 10.89% |
| Net Property, Plant & Equipment | -1.49% | -0.56% | -1.14% | -0.39% | -1.25% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -2.74% | -2.67% | -2.60% | -2.53% | -2.47% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -5.71% | -0.66% | -0.93% | 19.07% | 1.63% |
| Total Assets | -2.35% | 0.61% | -3.20% | -1.45% | 4.34% |
|
|
|||||
| Total Accounts Payable | 177.38% | -69.27% | 28.51% | -18.27% | -38.66% |
| Total Accrued Expenses | -10.59% | 28.91% | -5.79% | 4.04% | -1.55% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -14.66% | 0.39% | 297.57% | 14.77% | 32.30% |
| Total Finance Division Other Current Liabilities | -1.54% | 9.62% | 4.47% | 7.30% | -52.38% |
| Total Other Current Liabilities | -1.54% | 9.62% | 4.47% | 7.30% | -52.38% |
| Total Current Liabilities | -5.35% | 10.36% | 20.57% | 3.29% | -23.23% |
|
|
|||||
| Total Current Liabilities | -5.35% | 10.36% | 20.57% | 3.29% | -23.23% |
| Long-Term Debt | 0.37% | 0.36% | -6.18% | 0.35% | 20.29% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -1.17% | -1.13% | -1.11% | -1.11% | -1.06% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 145.75% | -76.99% | -22.53% | 27.72% | 1.70% |
| Total Liabilities | -0.59% | 0.93% | -0.45% | 1.51% | 4.98% |
|
|
|||||
| Common Stock & APIC | 0.58% | 0.60% | 1.06% | 0.78% | 2.72% |
| Retained Earnings | -1.37% | -0.77% | -2.42% | -2.36% | -3.08% |
| Treasury Stock & Other | 0.00% | -56.25% | 48.39% | 13.89% | -44.00% |
| Total Common Equity | -18.62% | -4.56% | -46.86% | -110.13% | -35.33% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -18.62% | -4.56% | -46.86% | -110.13% | -35.33% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -18.62% | -4.56% | -46.86% | -110.13% | -35.33% |
|
|
|||||